CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise | +24,100 | $3.18 | $77K | 35,323 |
| 2026-06-25 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale | −24,100 | $30.38 | $732K | 11,223 |
| 2026-06-25 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (Right to Buy) | −24,100 | 91,980 | ||
| 2026-06-25 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise | +24,100 | $3.18 | $77K | 54,647 |
| 2026-06-25 | Krasney Karen EVP, GENERAL COUNSEL | Sale | −24,100 | $30.38 | $732K | 30,547 |
| 2026-06-25 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise · Stock Option (Right to Buy) | −24,100 | 31,261 | ||
| 2026-06-24 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise | +400 | $3.18 | $1K | 11,623 |
| 2026-06-24 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale | −400 | $30.00 | $12K | 11,223 |
| 2026-06-24 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (Right to Buy) | −400 | 116,080 | ||
| 2026-06-24 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise | +400 | $3.18 | $1K | 30,947 |
| 2026-06-24 | Krasney Karen EVP, GENERAL COUNSEL | Sale | −400 | $30.00 | $12K | 30,547 |
| 2026-06-24 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise · Stock Option (Right to Buy) | −400 | 55,361 | ||
| 2026-06-22 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise | +500 | $3.18 | $2K | 11,723 |
| 2026-06-22 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale | −500 | $30.00 | $15K | 11,223 |
| 2026-06-22 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (Right to Buy) | −500 | 116,480 | ||
| 2026-06-22 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise | +500 | $3.18 | $2K | 31,047 |
| 2026-06-22 | Krasney Karen EVP, GENERAL COUNSEL | Sale | −500 | $30.00 | $15K | 30,547 |
| 2026-06-22 | Krasney Karen EVP, GENERAL COUNSEL | Option exercise · Stock Option (Right to Buy) | −500 | 55,761 | ||
| 2026-05-26 | Maurer Michael T CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2026-05-18 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise | +3,000 | $1.39 | $4K | 11,223 |
Page 1 of 24 · 468 trades